Showing results (151-160 of 274) with videos related to

Sort By:
Pageof 28
Journal of Pharmaceutical Sciences|November 1, 1981
Pharmacokinetics of sustained serum methotrexate concentrations secondary to gastrointestinal obstructionW E Evans, A Tsiatis, W R Crom, et al.
Clinical Pharmacology and Therapeutics|September 1, 1991
Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjectsM V Relling, J Cherrie, M J Schell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemiaC Ito, W E Evans, L McNinch, et al.
Cancer Research|March 1, 1984
Teniposide (VM26) disposition in children with leukemiaJ A Sinkule, C F Stewart, W R Crom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1986
Etoposide pharmacokinetics in patients with normal and abnormal organ functionS G Arbuck, H O Douglass, W R Crom, et al.
Cancer Research|July 15, 1990
Pharmacokinetics of continuous infusion of methotrexate and teniposide in pediatric cancer patientsJ H Rodman, M Sunderland, R L Kavanagh, et al.
Mayo Clinic Proceedings|September 1, 1991
Lipoprotein analysis in the evaluation of chest pain in the emergency departmentP C Gay, R A Nishimura, C S Roth, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 1995
A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferaseE Y Krynetski, J D Schuetz, A J Galpin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Increased teniposide clearance with concomitant anticonvulsant therapyD K Baker, M V Relling, C H Pui, et al.
Pageof 28